Proactive Investors - Run By Investors For Investors

Cosmos Holdings acquires Cosmofarm in Greece

Cosmofarm, a pharmaceutical wholesaler, reported sales of about $14 million in fiscal 2017
Cosmofarm logo
Athens-based Cosmofarm is in the process of relocating to a new 32,000 square foot facility

Cosmos Holdings Inc (OTCQB:COSM) has closed its acquisition of Cosmofarm Ltd, a privately held pharmaceutical company based in Greece.

Established in 1994, Cosmofarm is a pharmaceutical wholesale company in Athens, which provides a comprehensive range of pharmaceutical products. Its core business focuses on sourcing and distributing branded and generic medicines, over-the-counter pharmaceuticals, food supplements and medical devices to more than 1,130 pharmacies.

READ: Cosmos posts 3Q profit and strong profit margins on booming drug sales and bolstered balance sheet

Cosmofarm conducts business with as many as 250 pharmaceutical manufacturers and wholesalers and reported sales of about $14 million for the 2017 fiscal year.

The financial details of the Cosmofarm acquisition haven’t been disclosed.

Cosmos Holdings CEO Gregory Siokas is bullish about the takeover and so are investors who sent Cosmos shares up by 9.4% to $3.50 in Friday’s morning trading session.

READ: Cosmos Holdings focuses on Europe as it expands its global wholesale pharmaceutical business

“We are excited to announce the closing of this acquisition and to have Cosmofarm’s talented team become part of Cosmos Holdings,” Siokas said. “Cosmofarm will play a key role in increasing sales of our SkyPremium Life product line to pharmacies."

Cosmofarm is in the process of relocating to a new 32,000 square foot facility that features a robotic fulfillment center and offers 20 times the capacity of its old warehouse, according to Siokas.

Cosmos Holdings Inc. is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and in Harlow, UK.  The Chicago-based company conducts business in Germany, the United Kingdom, Ireland, the United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Jordan, Sweden, Poland, the Netherlands, and Greece. 


Contact Ellen Kelleher at [email protected] 

View full COSM profile View Profile

Cosmos Holdings Inc Timeline

July 02 2018

Related Articles

Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
Vial of pills
June 25 2018
Cosmos is a modern company, but the trade routes it relies on are ancient
A double helix and a medical person
March 06 2019
Leronlimab, according to the company, is an antiviral agent candidate with fewer side effects, lower toxicity and less frequent doses than daily HIV therapies now in use
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use